Somewhat more consistent findings have been reported for changes in KLC1 in AD, with decreased protein levels [45–47] speculated to contribute to reduced anterograde axonal transport; nevertheless, others found no change in KLC1 [48]. This evidence concerns the gene KLC1 and Alzheimer disease.